Documented History · Lab Testing · Patent Records

The Evidence Behind Maxilin

Maxilin is supported by decades of clinical records, pharmacological approvals, patent documentation, and independent laboratory testing.

Evidence Summary

Key Records at a Glance

1993First registered as a natural medicine by the Kazakhstan Pharmacological Commission.
30+ yearsDocumented clinical and supervised use across multiple health settings.
20B CFUIndependent 2024 lab testing confirmed lactic acid microorganisms per sachet.
0 coliformsIndependent testing reported no coliform contamination.
Supporting Documents

Open the Maxilin Evidence Documents

Click any document below to view the uploaded evidence record in a new tab.

Maxilin registered as natural medicine document

Registered as Natural Medicine

1993 registration record for Maxilin as a natural medicine.

Open Document
Maxilin treatment for patients document

Treatment for Patients

Clinical use record covering patient treatment documentation.

Open Document
Maxilin treatment gynaecology document

Gynaecology Treatment Record

Documented Maxilin use in a gynaecology setting.

Open Document
Maxilin treatment paediatrics document

Paediatrics Treatment Record

Documented Maxilin use in paediatric treatment records.

Open Document
Maxilin invention patent document

Invention Patent

Patent document covering the Maxilin invention record.

Open Document
Ownership transfer of Maxilin patent document

Patent Ownership Transfer

Record of ownership transfer for the Maxilin patent.

Open Document
Registration of trademark document

Trademark Registration

Trademark registration document for the Maxilin brand.

Open Document
Copyright certificate document

Copyright Certificate

Copyright certificate supporting the Maxilin documentation set.

Open Document
PubMed findings document

PubMed Findings

Research findings document included with the evidence materials.

Open Document
Maxilin availability document

Maxilin Availability

Availability document included with the supporting records.

Open Document
Maxilin approved in India document

Approved in India

India approval document included with the evidence set.

Open Document
Documented History

Clinical and Regulatory Timeline

These milestones summarize the records referenced across Maxilin's clinical acts, approvals, patent documents, and lab reports.

19 Feb 1993

Registered as a natural medicine

Approved by the Pharmacological Commission in Kazakhstan under Protocol No. 12.

Apr-Jun 1993

First supervised clinical use

Used for dysbacteriosis at the 1st Polyclinic Association in Almaty.

Aug-Oct 1994

Gynaecology trial

Republican Military Polyclinic records documented restoration of healthy flora within 5-7 days.

Oct-Dec 1994

Paediatric trial

Institute of Pediatrics, Almaty documented supervised use for children with intestinal dysbacteriosis and related conditions.

Oct 2010

Eurasian Patent No. 014227

Patent granted for the method of obtaining Maxilin and correcting microflora in humans and animals.

Sep 2024

Independent lab testing

Almaty Technological University Test Report No. 798 confirmed 20 billion CFU lactic acid microorganisms and zero coliforms.

Dec 2025

FSSAI Central License

EnergyMax Global Private Limited received Central License No. 12725999000778 in India.

What the Records Support

Evidence Areas

Natural strain source

Maxilin uses L. acidophilus 2585, presented as a naturally sourced strain refined over decades.

Antibiotic compatibility

Records describe resistance to multiple antibiotics, supporting use during antibiotic courses.

Synbiotic formulation

The formula combines probiotic bacteria with inulin, the prebiotic food source that supports bacterial viability.

Safety history

Site documentation reports no contraindications or adverse effects across long-term recorded use.

Comparison

How the Evidence Compares

FactormaXilin™Standard Probiotic
SourceNatural L. acidophilus 2585Often synthetically manufactured
Probiotic + prebioticSynbiotic, includes inulinOften bacteria only
Antibiotic resistanceDocumented resistance profileOften destroyed by antibiotics
Clinical recordsClinical acts and patent historyVaries by product
Lab testing2024 CFU and coliform testing citedVaries by brand and batch

Want the Supporting Documents?

Contact Terry to ask about the clinical acts, patent references, licensing records, and lab reports behind Maxilin.

Want to Know More?

Prefer an accessible introduction first? Read The Strength of the Gut Microbiome.